Timing of postmenopausal estrogen for optimal bone mineral density. The Rancho Bernardo Study.

OBJECTIVE To determine the effect of the timing of initiation and the duration of postmenopausal estrogen therapy on bone mineral density (BMD). DESIGN Cross-sectional study. SETTING White, middle-class to upper middle-class community-dwelling women. PARTICIPANTS A total of 740 women aged 60 to 98 years who participated in a study of osteoporosis. MEASUREMENTS Questionnaire, validated medication use, and height and weight. Bone mineral density at the ultradistal radius and midshaft radius using single-photon absorptiometry (SPA) and at the hip and lumbar spine using dual-energy x-ray absorptiometry (DEXA). RESULTS Of the 740 women, 69% had used oral estrogen after menopause and 30% were current users. Five groups of estrogen use were identified: never users, past users who started at menopause, past users who started after age 60 years, current users who started after age 60 years, and current users who started at menopause. At all 4 bone sites, current users who started at menopause had the highest BMD levels, which were significantly higher than never users or past users who started at menopause (with 10 years' duration of use). These differences persisted after controlling for all major risk factors for osteoporosis. Among current users, there was no significant difference in BMD levels at any site between those who started estrogen at menopause (with 20 years of use) and those who started after age 60 years (with 9 years of use). CONCLUSIONS Estrogen initiated in the menopausal period and continued into late life is associated with the highest bone density. Nevertheless, estrogen begun after age 60 years and continued appears to offer nearly equal bone-conserving benefit.

[1]  S. Cummings,et al.  Estrogen Replacement Therapy and Fractures in Older Women , 1995, Annals of Internal Medicine.

[2]  H. Genant,et al.  Postmenopausal bone loss is prevented by treatment with low-dosage estrogen with calcium. , 1987, Annals of internal medicine.

[3]  D. Kiel,et al.  The effect of postmenopausal estrogen therapy on bone density in elderly women. , 1993, The New England journal of medicine.

[4]  I. Reid,et al.  Continuous combined oestrogen/progestin therapy is well tolerated and increases bone density at the hip and spine in post‐menopausal osteoporosis , 1994, Clinical endocrinology.

[5]  J. Brody,et al.  Absence of menopausal effect on hip fracture occurrence in white females. , 1984, American journal of public health.

[6]  J. Kelsey,et al.  An epidemiologic study of hip fracture in postmenopausal women. , 1982, American journal of epidemiology.

[7]  A. Lane,et al.  Treatment of Postmenopausal Osteoporosis with Transdermal Estrogen , 1992, Annals of Internal Medicine.

[8]  R. Lindsay,et al.  Oestrogen Replacement Therapy for Prevention of Osteoporosis after Oophorectomy , 1973, British medical journal.

[9]  E. Atra,et al.  Do estrogens improve bone mass in osteoporotic women over ten years of menopause. , 1994, Sao Paulo medical journal = Revista paulista de medicina.

[10]  C. Christiansen,et al.  17 Beta-estradiol and continuous norethisterone: a unique treatment for established osteoporosis in elderly women. , 1990, The Journal of clinical endocrinology and metabolism.

[11]  B. Ettinger,et al.  The waning effect of postmenopausal estrogen therapy on osteoporosis. , 1993, The New England journal of medicine.

[12]  R. Lindsay,et al.  BONE RESPONSE TO TERMINATION OF ŒSTROGEN TREATMENT , 1978, The Lancet.

[13]  R. Lindsay,et al.  The Minimum Effective Dose of Estrogen for Prevention of Postmenopausal Bone Loss , 1984, Obstetrics and gynecology.

[14]  C. Christiansen,et al.  BONE MASS IN POSTMENOPAUSAL WOMEN AFTER WITHDRAWAL OF OESTROGEN/GESTAGEN REPLACEMENT THERAPY , 1981, The Lancet.

[15]  R. Lindsay,et al.  PREVENTION OF SPINAL OSTEOPOROSIS IN OOPHORECTOMISED WOMEN , 1980, The Lancet.

[16]  R. Lindsay,et al.  LONG-TERM PREVENTION OF POSTMENOPAUSAL OSTEOPOROSIS BY ŒSTROGEN EVIDENCE FOR AN INCREASED BONE MASS AFTER DELAYED ONSET OF ŒSTROGEN TREATMENT , 1976, The Lancet.

[17]  N. Weiss,et al.  Decreased risk of fractures of the hip and lower forearm with postmenopausal use of estrogen. , 1980, The New England journal of medicine.

[18]  D. Muchmore,et al.  Do estrogens improve bone mineral density in osteoporotic women over age 65? , 1992, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[19]  R. Heaney Estrogen-calcium interactions in the postmenopause: a quantitative description. , 1990, Bone and mineral.

[20]  E. Beckman Estrogen Replacement Therapy I: A 10-Year Prospective Study in the Relationship to Osteoporosis , 1979, Obstetrics and gynecology.

[21]  T. Hutchinson,et al.  POST-MENOPAUSAL ŒSTROGENS PROTECT AGAINST FRACTURES OF HIP AND DISTAL RADIUS A Case-control Study , 1979, The Lancet.

[22]  J. Birkenhäger,et al.  Can nandrolone add to the effect of hormonal replacement therapy in postmenopausal osteoporosis? , 1992, Bone and mineral.

[23]  L. Melton,et al.  Relative contributions of aging and estrogen deficiency to postmenopausal bone loss. , 1984, The New England journal of medicine.

[24]  J. Eisman,et al.  Effects of estrogen exposure and reproductive factors on bone mineral density and osteoporotic fractures. , 1995, The Journal of clinical endocrinology and metabolism.

[25]  M. Quigley,et al.  Estrogen therapy arrests bone loss in elderly women. , 1987, American journal of obstetrics and gynecology.

[26]  W. Willett,et al.  Reproducibility and validity of a semiquantitative food frequency questionnaire. , 1985, American journal of epidemiology.

[27]  H. Pols,et al.  Course of bone mass during and after hormonal replacement therapy with and without addition of nandrolone decanoate , 1994, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[28]  H. Genant,et al.  Long-term estrogen replacement therapy prevents bone loss and fractures. , 1985, Annals of internal medicine.

[29]  B. Ettinger,et al.  Maximizing the Benefit of Estrogen Therapy for Prevention of Osteoporosis , 1994 .

[30]  R. Lindsay,et al.  Estrogen treatment of patients with established postmenopausal osteoporosis , 1990, Obstetrics and gynecology.